Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

This study has been completed.
The norwegian association for heart and lung patients
Information provided by:
LHL Helse
ClinicalTrials.gov Identifier:
First received: November 4, 2005
Last updated: April 12, 2007
Last verified: April 2007

The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Condition Intervention
Drug: oxygen

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Diagnostic

Resource links provided by NLM:

Further study details as provided by LHL Helse:

Primary Outcome Measures:
  • dyspnea
  • exercise tolerance

Estimated Enrollment: 20
Study Start Date: October 2005
Study Completion Date: April 2007

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • COPD patients (male/female)given long-term oxygen treatment
  • Able to perform two separate walking tests

Exclusion Criteria:

  • Severe heart failure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00249093

Hakadal, Norway, 1485
Sponsors and Collaborators
LHL Helse
The norwegian association for heart and lung patients
Principal Investigator: Morten S Ryg, dr philos LHL Helse
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00249093     History of Changes
Other Study ID Numbers: G25-1
Study First Received: November 4, 2005
Last Updated: April 12, 2007
Health Authority: Norway:National Committee for Medical and Health Research Ethics

ClinicalTrials.gov processed this record on October 06, 2015